Rezubio Pharmaceuticals Co., Ltd.
PrivateLast Round
Series A
Dec 18, 2025
Total Funding Raised
$20M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Rezubio Pharmaceuticals Co., Ltd. is a biotechnology company that develops tissue-selective therapeutics for metabolic, inflammatory, and degenerative diseases using its proprietary Membrane-Anchored Drug Design (MADD) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rezubio Pharmaceuticals Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Rezubio Pharmaceuticals Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 18, 2025 | ||||
| Pre Seed | Feb 16, 2023 | ||||
| Angel | Sep 1, 2019 |
Rezubio Pharmaceuticals Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GF Qianhe Investment | Pre Seed |
| Lapam Capital | Series A |
| Huajin Capital | Pre Seed |
| Hengqin Financial Investment Group | Angel |
| Hanne Capital | Angel |
| Sunshine Riverhead Capital Investment Management Co., Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 18, 2025
$20M round led by Lapam Capital
Rezubio Pharmaceuticals Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rezubio Pharmaceuticals Co., Ltd.'s valuation, stock price, and market status.